
Ron Leuty
@rleuty_biotech
#Biotech reporter @SFBusinessTimes; hardcore @Tigers fan; once rolled a 288. Tip me: [email protected], Signal or 415-722-2678. Also find me on bluesky.
ID: 194343133
http://bit.ly/1mAMrUQ 23-09-2010 22:19:15
29,29K Tweet
11,11K Followers
1,1K Following


Former 23andMe CEO Anne Wojcicki's nonprofit closes deal to buy the genetic testing company in a bankruptcy court sale. Here's what it means for the company, customers and shareholders. bizjournals.com/sanfrancisco/n… via San Francisco Business Times

Corcept Therapeutics asks FDA to approve relacorilant in ovarian cancer — how it got here from a rare disease bizjournals.com/sanfrancisco/n… via San Francisco Business Times



Sarepta Therapeutics begins layoffs amid gene therapy challenges - Boston Business Journal bizjournals.com/boston/news/20… via Boston Business Journal

Gladstone Institutes weighs buying Mission Bay space bizjournals.com/sanfrancisco/n… via San Francisco Business Times

Boston lab leases double in Q2 2025, but vacancy remains high bizjournals.com/boston/news/20… via Boston Business Journal

“Not working with us in good faith”: How a biotech innovator lost its landlord's confidence bizjournals.com/sanfrancisco/n… via San Francisco Business Times

Freenome look to complete filing for FDA approval of simple blood test for colorectal cancer bizjournals.com/sanfrancisco/n… via San Francisco Business Times


IQHQ asks to extend timeline for $1.3B Peninsula biotech project bizjournals.com/sanfrancisco/n… via San Francisco Business Times

That viral Coldplay concert moment shows society needs to grow up "Let’s be honest about what this is: a toxic cycle of voyeurism masquerading as social commentary. There is no public interest being served. No investigative journalism." sfchronicle.com/opinion/openfo… via San Francisco Chronicle



$200M Stanford, UCSF 'cancer hub' launched with gift from Sandy and Joan Weill bizjournals.com/sanfrancisco/n… via San Francisco Business Times

A Swiss company bought Genentech's former Vacaville plant — here's how it's going so far bizjournals.com/sanfrancisco/n… via San Francisco Business Times



Meet the Bay Area biotech that just raised a megaround to focus on schizophrenia and Alzheimer's-related psychosis bizjournals.com/sanfrancisco/n… via San Francisco Business Times